"Digital health tools are shifting the paradigm for companies developing new therapeutics or medical devices, from early-stage innovation through the entire lifecycle of a product – with potential to make innovation more efficient, extend business lines and enhance provider and patient relationships. Bob Coughlin, president and CEO of Mass Biotech Council, will be speaking on this subject and the long view of pharma and digital on October 16 at the..." Lire la suite
